CINIE CINIE
中文 | English | Français | Русский
Home CINIE World Nuclear Fusion Nuclear Application

Search Results

Keyword:medical radionuclides

Maistop Completes Pre-A Round Financing to Advance Medical Radionuclide Industrialization via Electron Accelerator Method

Maistop Completes Pre-A Round Financing to Advance Medical Radionuclide Industrialization via Electron Accelerator Method

August 12 news, Xi'an Maistop Technology Co., Ltd. recently completed its Pre-A round of financing, with investors including the Central Enterprise Strategic Emerging Fund and Guoxin Venture Capital Fund, both under China Reform Holdings Corporation. The proceeds from this round will primarily be used for site construction, equipment procurement, technology R&D, and daily operations. Founded in 2019, Maistop is a technology enterprise engaged in the R&D and production of medical radionuclides as well as nuclear medicine technical services. The company focuses on the preparation of medical radionuclides via the electron accelerator photonuclear reaction method, with core products including Actinium-225, Lead-212, Copper-67, and Molybdenum-99. Among these, Actinium-225 is a scarce radionuclide of significant interest in alpha-emitting nuclide targeted therapy, with relatively strong global clinical demand...

2026-08-13

Reading Ranking

  • 1 US Nuclear Regulatory Commission Delays Review Milestone for Orano Enrichment Plant
  • 2 Russia's Seversk launches core basket assembly for lead-cooled fast reactor
  • 3 Rosatom Commissions Hot and Cold Testing of Akkuyu Unit 1
  • 4 ENTRA1 Energy Partners with Sargent & Lundy to Advance SMR Deployment
  • 5 White & Case LLP Reports Global Nuclear M&A Reaches USD 10.3 Billion in First Nine Months
  • 6 IAEA Acknowledges Safety Commitment of Shin Kori Unit 2
  • 7 Skanska Completes Seismic Bearings for Rolls-Royce SMR
  • 8 NASA Plans to Launch Nuclear-Powered Mars Spacecraft by Late 2028
  • 9 Norway Funds Marine Nuclear Power System Integration Testing
  • 10 Society of Nuclear Medicine and Molecular Imaging Awards Dr. Calais the Gambhir Lecture Award
  • 11 Russian Regulator Reviews Zaporizhzhia Unit 3 Licence
  • 12 The Nuclear and Radiation Safety Center of the Ministry of Ecology and Environment Holds Briefing on New Standard
  • 13 France Releases Ten-Year Nuclear Fusion Energy Development Strategy Roadmap
  • 14 South China Regional Office carries out supervision of core equipment at Changjiang Small Modular Reactor
  • 15 Middle East Powers Accelerate Civil Nuclear Energy Strategic Deployment
CINIE

Organizing Committee of the Shenzhen Nuclear Expo

Telephone: +86 10-67808008

+86 10-68808008

Email: info@cinie.net

CINIE

Event Overview Support Services Highlights Archive Contact Us

World Nuclear

China Nuclear Power News World Nuclear Power News Expert Views Nuclear Power Technology

Fusion

China Fusion World Fusion Big Science Facilities ITER Program Business & Capital

Nuclear Application

Medical Scientific Research Environmental Protection Industry Food Agriculture Security
About us | All rights reserved
CINIE All rights reserved 2026 ICP License:京ICP备12027382号-9